Hi, what are you looking for?
Jewish Business News
Search results for "biotech"
Business
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about...
Money
On his Tuesday, November 11th episode of Mad Money on CNBC, Cramer identified 3 sectors that are leading stocks: Biotech, Housing and “Cult Stocks.”...
Business
Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are...
Business
– Clal Biotechnology and Hyperion have agreed on an independent assessment of Andromeda’s Type 1 diabetes treatment. – Clal Biotechnology (TASE: CBI), managed...
Court
Clal Biotechnology Industries Ltd. (TASE: CBI announced yesterday that it had filed a $200 million suit against drug company Hyperion Therapeutics Inc. (Nasdaq: HPTX)...
World News
Clal Biotechnology Industries Ltd. (TASE: CBI) notified the Tel Aviv Stock Exchange this morning that it had contacted Hyperion Therapeutics Inc. (Nasdaq: HPTX) as...
Business
– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company...
Business
By Gali Weinreb and Shiri Habib-Valdhorn Hyperion says it has “uncovered evidence” that Andromeda falsified clinical trial results. Hyperion Therapeutics Inc. (Nasdaq: HPTX) has...
World News
– On CNBC’s Mad Dash, Cramer discussed the powerful performance of biotech stock Intercept (ICPT) which saw a 16.59% increase on Tuesday after strong...
Money
Fed Chief Janet Yellen is concerned that the flight to high-risk assets and junk bonds could lead to a financial bubble.